News and events

  • All
  • Events
  • Press releases
  • Publications
All
  • All
  • Events
  • Press releases
  • Publications

VHH-Fc fusion molecules for prophylactic and therapeutic purposes against respiratory infections

Poster presented at the Antibody Engineering & Therapeutics Congress, December ...
Read More

ExeVir Bio Announces Positive Virus Neutralization Data for XVR012 Against Emerging COVID-19 Omicron Variants

Read More

Bio-Europe – November 6-8, 2023 – Munich, Germany

Our CEO Torsten Mummenbrauer is attending #BIOEurope in Munich, November 6-8!
Read More

ExeVir Bio Appoints a Chief Scientific Officer

Ghent, Belgium, 1 September 2023: ExeVir Bio, a biotech company ...
Read More

ExeVir Bio Awarded EUR 1.6m Grant for Dengue Research

Dengue is a mosquito borne viral infection listed by WHO as top 10 threat for global health The government grant is awarded by Flanders Innovation ...
Read More